- Home
- TARA vs MCR Comparison
TARA vs MCR Comparison
Compare TARA & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARA | MCR |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 246.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARA | MCR |
|---|---|---|
| Price | $5.17 | $6.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $23.60 | N/A |
| AVG Volume (30 Days) | ★ 523.4K | 94.7K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.52% |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $5.84 |
| 52 Week High | $7.82 | $6.57 |
Technical Indicators
Market Signals| Indicator | TARA | MCR |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 42.96 |
| Support Level | $4.92 | $6.00 |
| Resistance Level | $5.44 | $6.36 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 41.54 | 42.11 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.